Endothelial damage in white coat hypertension: Role of lectin-like oxidized low-density lipoprotein-1

Journal of Human Hypertension

Volumn 29, Issue 2, 2015, Pages 92-98

  Yavuzer, S ^a   Yavuzer, H ^a   Cengiz, M ^a   Erman, H ^a   Altparmak, M R ^a   Korkmazer, B ^a   Balci, H ^a   Simsek, G ^a   Yaldran, A L ^a   Karter, Y ^a   Uzun, H ^a  

^a ISTANBUL UNIVERSITY   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR 1; BIOLOGICAL MARKER; ENDOTHELIAL NITRIC OXIDE SYNTHASE; LOW DENSITY LIPOPROTEIN; NOS3 PROTEIN, HUMAN; OLR1 PROTEIN, HUMAN;

ADULT; ARTERIAL WALL THICKNESS; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR RISK; COMPARATIVE STUDY; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENZYME ACTIVATION; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; WHITE COAT HYPERTENSION; BLOOD; CASE CONTROL STUDY; ECHOGRAPHY; METABOLISM; VASCULAR ENDOTHELIUM;

ADULT; BIOMARKERS; CAROTID INTIMA-MEDIA THICKNESS; CASE-CONTROL STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; SCAVENGER RECEPTORS, CLASS E; WHITE COAT HYPERTENSION;

EID: 84926193914     PISSN: 09509240     EISSN: 14765527     Source Type: Journal    
DOI: 10.1038/jhh.2014.55     Document Type: Article

References (37)

1. Kearney PM, Whelton M, Reynolds K, Whelton PK, He J. Worldwide prevalence of hypertension: a systematic review. J Hypertens 2004; 22: 11-19.
2. Pickering TG, James GD, Boddie C, Harshfield GA, Blank S, Laragh JH. How common is white coat hypertension? JAMA 1988; 259: 225-228.
3. Franklin SS, Thijs L, Hansen TW, O'Brien E, Staessen JA. White-coat hypertension: new insights from recent studies. Hypertension 2013; 62: 982-987.
4. Nakashima T, Yamano S, Sasaki R, Minami S, Doi K, Yamamoto J et al. White-coat hypertension contributes to the presence of carotid arteriosclerosis. Hypertens Res 2004; 27: 739-745.
5. Taye A, El-Sheikh AA. Lectin-like oxidized low-density lipoprotein receptor 1 pathways. Eur J Clin Invest 2013; 43: 740-745.
6. Kume N, Kita T. Roles of lectin-like oxidized LDL receptor-1 and its soluble forms in atherogenesis. Curr Opin Lipidol 2001; 12: 419-423.
7. Morawietz H. LOX-1 receptor as a novel target in endothelial dysfunction and atherosclerosis. Dtsch Med Wochenschr 2010; 135: 308-312.
8. Keidar S, Kaplan M, Hoffman A, Aviram M. Angiotensin II stimulates macrophage mediated oxidation of low density lipoproteins. Atherosclerosis 1995; 115: 201-205.
9. Hermann M, Flammer A, Lu?scher TF. Nitric oxide in hypertension. J Clin Hypertens (Greenwich) 2006; 8: 17-29.
10. O'Brien E, Waeber B, Parati G, Staessen J, Myers MG. Blood pressure measuring devices: recommendations of the European Society of Hypertension. BMJ 2001; 322: 531-536.
11. O'Brien E, Coats A, Owens P, Petrie J, Padfield PL, Littler WA et al. Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British Hypertension Society. BMJ 2000; 320: 1128-1134.
12. Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation 1986; 74: 1399-1406.
13. American Diabetes Association. Diabetic nephropathy. Diabetes Care 2003; 26(Suppl 1): S94-S98.
14. Rietzschel ER, Langlois M, De Buyzere ML, Segers P, De Bacquer D, Bekaert S et al. for the Asklepios Investigators. Oxidized low-density lipoprotein cholesterol is associated with decreases in cardiac function independent of vascular alterations. Hypertension 2008; 52: 535-541.
15. Toikka JO, Laine H, Ahotupa M, Haapanen A, Viikari JS, Hartiala JJ et al. Increased arterial intima-media thickness and in vivo LDL oxidation in young men with borderline hypertension. Hypertension 2000; 36: 929-933.
16. Quiñ ones-Galvan A, Pucciarelli A, Fratta-Pasini A, Garbin U, Franzoni F, Galetta F et al. Effective blood pressure treatment improves LDL-cholesterol susceptibility to oxidation in patients with essential hypertension. J Intern Med 2001; 250: 322-326.
17. Assadpoor-Piranfar M, Pordal AH, Beyranvand MR. Measurement of oxidized low-density lipoprotein and superoxide dismutase activity in patients with hypertension. Arch Iran Med 2009; 12: 116-120.
18. Chrysohoou C, Panagiotakos DB, Pitsavos C, Skoumas J, Economou M, Papadimitriou L et al. The association between pre-hypertension status and oxidative stress markers related to atherosclerotic disease: the ATTICA study. Atherosclerosis 2007; 192: 169-176.
19. Uzun H, Karter Y, Aydin S, Curgunlu A, Simşek G, Yu?cel R et al. Oxidative stress in white coat hypertension; role of paraoxonase. J Hum Hypertens 2004; 18: 523-528.
20. Vindis C, Escargueil-Blanc I, Elbaz M, Marcheix B, Grazide MH, Uchida K et al. Desensitization of platelet-derived growth factor receptor-beta by oxidized lipids in vascular cells and atherosclerotic lesions: prevention by aldehyde scavengers. Circ Res 2006; 98: 785-792.
21. Li DY1, Zhang YC, Philips MI, Sawamura T, Mehta JL. Upregulation of endothelial receptor for oxidized low-density lipoprotein (LOX-1) in cultured human coronary artery endothelial cells by angiotensin II type 1 receptor activation. Circ Res 1999; 84: 1043-1049.
22. Nagase M, Hirose S, Sawamura T, Masaki T, Fujita T. Enhanced expression of endothelial oxidized low-density lipoprotein receptor (LOX-1) in hypertensive rats. Biochem Biophys Res Commun 1997; 237: 496-498.
23. Morawietz H, Rueckschloss U, Niemann B, Duerrschmidt N, Galle J, Hakim K et al. Angiotensin II induces LOX-1, the human endothelial receptor for oxidized low density lipoprotein. Circulation 1999; 100: 899-902.
24. Panza JA1, Quyyumi AA, Brush Jr JE, Epstein SE. Abnormal endotheliumdependent vascular relaxation in patients with essential hypertension. New Engl J Med 1990; 323: 22-27.
25. Mehta JL, Li D. Identification, regulation and function of a novel lectin-like oxidized low-density lipoprotein receptor. J Am Coll Cardiol 2002; 39: 1429-1435.
26. Ando K, Fujita T. Role of lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1) in the development of hypertensive organ damage. Clin Exp Nephrol 2004; 8: 178-182.
27. Akhmedov A, Rozenberg I, Paneni F, Camici GG, Shi Y, Doerries C et al. Endothelial overexpression of LOX-1 increases plaque formation and promotes athero-sclerosis in vivo. Eur Heart J (e-pub ahead of print 12 January 2014; doi:10.1093/eurheartj/eht532).
28. Dominiczak AF, Bohr DF. Nitric oxide and its putative role in hypertension. Hypertension 1995; 25: 1202-1211.
29. Zavaroni I, Ardigo D, Rossi PC, Zuccarelli A, Pacetti E, Monti L et al. Relationship between plasma nitric oxide concentration and insulin resistance in essential hypertension. Am J Hypertens 2004; 17: 549-552.
30. Cittadino M, Goncalves de Sousa M, Ugar-Toledo JC, Rocha JC, Tanus-Santos JE, Moreno Jr H. Biochemical endothelial markers and cardiovascular remodeling in refractory arterial hypertension. Clin Exp Hypertens 2003; 25: 25-33.
31. Armas-Padilla MC, Armas-Herna?dez MJ, Sosa-Canache B, Cammarata R, Pacheco B, Guerrero J et al. Nitric oxide and malondialdehyde in human hypertension. Am J Ther 2007; 14: 172-176.
32. Kedziora-Kornatowska K, Kornatowski T, Bartosz G, Pawluk H, Czuczejko J, Kedziora J et al. Production of nitric oxide, lipid peroxidation and oxidase activity of ceruloplasmin in blood of elderly patients with primary hypertension. Effects of perindopril treatment. Aging Clin Exp Res 2006; 18: 1-6.
33. Karter Y, Aydin S, Curgunlu A, Uzun H, Ertu?rk N, Vehid S et al. Endothelium and angiogenesis in white coat hypertension. J Hum Hypertens 2004; 18: 809-814.
34. Curgunlu A, Uzun H, Bavunog? lu I, Karter Y, Genç H, Vehid S. Increased circulating concentrations of asymmetric dimethylarginine (ADMA) in white coat hypertension. J Hum Hypertens 2005; 19: 629-633.
35. Beierwaltes WH, Carretero OA. Nonprostanoid endothelium-derived factors inhibit renin release. Hypertension 1992; 19: 68-73.
36. Kra?er BK, Ritthaler T, Ackermann M, Holmer S, Schricker K, Riegger GA et al. Endothelium-mediated regulation of renin secretion. Kidney Int 1994; 46: 1577-1579.
37. Hein TW, Liao JC, Kuo L. oxLDL specifically impairs endothelium-dependent, NO-mediated dilation of coronary arterioles. Am J Physiol Heart Circ Physiol 2000; 278: H175-H183.